Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Ridgetech's share price for the quarter that ended in Sep. 2025 was €20303.999898. Ridgetech's Shares Outstanding (EOP) for the quarter that ended in Sep. 2025 was 0.0 Mil. Therefore, Ridgetech's market cap for the quarter that ended in Sep. 2025 was €791.9 Mil.
Ridgetech's quarterly market cap
declined
from Sep. 2024 (€893.4 Mil) to Mar. 2025 (€791.9 Mil) but then
stayed the same
from Mar. 2025 (€791.9 Mil) to Sep. 2025 (€791.9 Mil).
Ridgetech's annual market cap
increased
from Mar. 2023 (€162.4 Mil) to Mar. 2024 (€243.6 Mil) and
increased
from Mar. 2024 (€243.6 Mil) to Mar. 2025 (€791.9 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ridgetech's Enterprise Value for Today is €-7.2 Mil.
Ridgetech (FRA:7QL) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Ridgetech Market Cap Related Terms
Ridgetech Market Cap Historical Data
* Premium members only.
The historical data trend for Ridgetech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:7QL vs DHTI, PMHS, BLMH: Market Cap Comparison
For the Pharmaceutical Retailers subindustry, Ridgetech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ridgetech Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ridgetech's Market Cap distribution charts can be found below:
* The bar in red indicates where Ridgetech's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Ridgetech's Market Cap for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ridgetech (FRA:7QL) has a Market Cap of €1.0 Mil as of Jul. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ridgetech and its competitors. According to the industry distribution chart, Ridgetech ranks #676 out of 693 companies in the Healthcare Providers & Services industry, placing it in the top 97.5%.
Is Ridgetech's Market Cap too high?
Ridgetech's current Market Cap is €1.0 Mil. Based on the distribution chart, Ridgetech ranks #676 out of 693 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Ridgetech has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Ridgetech's Market Cap compare to DHTI and PMHS?
According to the Healthcare Providers & Services industry distribution chart, Ridgetech ranks #676 out of 693 companies for Market Cap. This places Ridgetech in the lower half of its industry. The industry median Market Cap is 103.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 103.69, based on 693 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ridgetech and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 103.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ridgetech's current Market Cap is €1.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ridgetech stock overvalued right now?
Ridgetech (FRA:7QL) has a current Market Cap of €1.0 Mil. The stock's GF Value™ is €2,118,249.18, compared to a current price of €20,304.00 — trading 99% below its estimated fair value. The current Market Cap is €1.0 Mil. Ridgetech's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Ridgetech (FRA:7QL), the current Market Cap is €1.0 Mil as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ridgetech (FRA:7QL) Overvalued in 2026?
Based on GuruFocus' analysis, Ridgetech stock appears to be undervalued.
The current stock price of €20,304.00 is trading 99% below its estimated GF Value™ of €2,118,249.18.
Key valuation signals for FRA:7QL:
Market Cap: €1.0 Mil
GF Value™: €2,118,249.18 vs. price of €20,304.00 (99% below fair value)
No single metric tells the full story. See the FRA:7QL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ridgetech Inc formerly China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.
40GF Score
Get the complete analysis for FRA:7QL
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7QL has been successfully added to your 
